Keywords: آنتی هیستامین H1; Chronic idiopathic urticaria; chronic spontaneous urticaria; H1-antihistamine; H2-antihistamines; hive; itch; leukotriene receptor antagonist; omalizumab; pruritus; wheal; AE; Adverse event; CIU/CSU; Chronic idiopathic urticaria/chronic spontaneous urtica
مقالات ISI آنتی هیستامین H1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Chronic inducible urticaria: AÂ systematic review of treatment options
Keywords: آنتی هیستامین H1; Urticaria; angioedema; inducible urticaria; omalizumab; antihistamines; review; AE; Adverse event; CindU; Chronic inducible urticaria; CSU; Chronic spontaneous urticaria; H1-AH; H1-antihistamine; ITT; Intention to treat; MD; Mean difference; RR; Risk rati
Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study
Keywords: آنتی هیستامین H1; Bilastine; Chronic spontaneous urticaria; DLQI; H1-antihistamine; Total symptom score; ANCOVA; analysis of covariance; CI; confidence interval; CSU; chronic spontaneous urticaria; DLQI; Dermatology Life Quality Index; FAS; full analysis set; QOL; quality
Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study
Keywords: آنتی هیستامین H1; Bilastine; Fexofenadine; H1-antihistamine; Perennial allergic rhinitis; Total nasal symptom score; AR; allergic rhinitis; SAR; seasonal allergic rhinitis; PAR; perennial allergic rhinitis; PET; positron emission tomography; TNSS; total nasal symptom score
Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber)
Keywords: آنتی هیستامین H1; Bilastine; Fexofenadine; H1-antihistamine; OHIO Chamber; Therapeutic effect; ADR; adverse drug reaction; AE; adverse event; ANCOVA; analysis of covariance; ANOVA; analysis of variance; AR; allergic rhinitis; CI; confidence interval; EEC; environmental exp
H1-antihistamines induce vacuolation in astrocytes through macroautophagy
Keywords: آنتی هیستامین H1; HTMT; trifluoromethyl toluidide; V-ATPase; vacuolar-ATPase; 3-MA; 3-methyladenine; MDC; monodansylcadaverine; BSA; bovine serum albumin; PBS; phosphate-buffered saline; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; Astrocyte; H1-antihistamine; Macroaut
Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6
Keywords: آنتی هیستامین H1; H1 receptor; H1-antihistamine; Histamine; Insomnia; Indene; CYP2D6; Biotransformation; pKa
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
Keywords: آنتی هیستامین H1; Chronic idiopathic urticaria; chronic spontaneous urticaria; H1-antihistamine; hive; itch; omalizumab; urticaria activity score; dose ranging; AE; Adverse event; CIU; Chronic idiopathic urticaria; nsAH; Nonsedating H1-antihistamine; UAS; Urticaria activit
Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia
Keywords: آنتی هیستامین H1; H1-Receptor; H1-Antihistamine; Histamine; Insomnia; Indene; CYP2D6; Biotransformation
Selectivity profiling of novel indene H1-antihistamines for the treatment of insomnia
Keywords: آنتی هیستامین H1; H1 receptor; H1-antihistamine; Insomnia; Indene; Histamine; SAR
Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: Piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1)
Keywords: آنتی هیستامین H1; QSAR; H1-antihistamine; Apex-3D; Catalyst
Levocetirizine: Pharmacokinetics and pharmacodynamics in children age 6 to 11 years
Keywords: آنتی هیستامین H1; H1-antihistamine; levocetirizine; pharmacokinetics; pharmacodynamics; wheal; flare; allergic rhinitis; urticaria; children; EC50; Plasma concentration producing 50% of Emax; Emax; Maximum effect attributable to medication;